Does Dr. CHARLEY ANDREWS III have financial conflicts of interest?

Dr. CHARLEY ANDREWS III (M.D.) has received a total of $98 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $98 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CHARLEY ANDREWS III?

According to CMS Open Payments data, Dr. CHARLEY ANDREWS III received funding from RAYNER INTRAOCULAR LENSES LIMITED ($50) and APELLIS PHARMACEUTICALS ($48).

Does Dr. CHARLEY ANDREWS III receive research grants or speaking fees?

Dr. CHARLEY ANDREWS III has received $98 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CHARLEY ANDREWS III

M.D.Real-Time Hydrated

Specialty: Ophthalmology

Practice Location: HURST, TX 76053

NPI Number: 1801882410

LIFETIME INDUSTRY VALUE

$98

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ANDREWS III is a verified Ophthalmology practitioner based in HURST, TX.

Between 2021 and 2025, Dr. ANDREWS III had an overall industry promotional and research financial footprint of $98 as recorded in the federal CMS Open Payments database.

$98 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANDREWS III's primary funding source is RAYNER INTRAOCULAR LENSES LIMITED, which accounts for $50 (representing 50.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

RAYNER INTRAOCULAR LENSES LIMITED

Rank 1

$50

50.8%

APELLIS PHARMACEUTICALS

Rank 2

$48

49.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.